ArticleScientific reports2025

Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells.

Methi Wathikthinnakon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.